a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs
Company profile
Ticker
PNT
Exchange
Website
CEO
Joe A. McCann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Therapeutics Acquisition Corp.
SEC CIK
PNT stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
8 Jan 24
EFFECT
Notice of effectiveness
3 Jan 24
EFFECT
Notice of effectiveness
3 Jan 24
POS AM
Prospectus update (post-effective amendment)
27 Dec 23
POS AM
Prospectus update (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
25-NSE
Exchange delisting
27 Dec 23
8-K
Termination of a Material Definitive Agreement
27 Dec 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm |
Cash burn (monthly) | 11.90 mm | 8.68 mm | 9.88 mm | (no burn) | 9.38 mm | (no burn) |
Cash used (since last report) | 81.57 mm | 59.53 mm | 67.72 mm | n/a | 64.30 mm | n/a |
Cash remaining | -59.96 mm | -37.92 mm | -46.11 mm | n/a | -42.70 mm | n/a |
Runway (months of cash) | -5.0 | -4.4 | -4.7 | n/a | -4.6 | n/a |
Institutional ownership, Q3 2023
66.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 130 |
Opened positions | 14 |
Closed positions | 17 |
Increased positions | 51 |
Reduced positions | 38 |
13F shares | Current |
---|---|
Total value | 407.96 bn |
Total shares | 70.79 mm |
Total puts | 800.90 k |
Total calls | 228.70 k |
Total put/call ratio | 3.5 |
Largest owners | Shares | Value |
---|---|---|
BVF | 10.56 mm | $70.46 bn |
Biotechnology Value Fund L P | 9.18 mm | $0.00 |
BLK Blackrock | 6.64 mm | $44.26 bn |
Vanguard | 4.67 mm | $31.13 bn |
STT State Street | 3.53 mm | $23.53 bn |
Great Point Partners | 2.91 mm | $19.41 bn |
Deep Track Capital | 2.78 mm | $18.55 bn |
Boxer Capital | 2.50 mm | $16.68 bn |
BLVGF Bellevue | 2.35 mm | $15.68 bn |
Citadel Advisors | 2.16 mm | $14.39 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Dec 23 | Yael Margolin | Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,710 | 0.00 | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.12 | 44,749 | 408.11 k | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.31 | 25,614 | 212.85 k | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 25,000 | 211.75 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.78 | 131,355 | 890.59 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.13 | 105,360 | 856.58 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 16,767 | 142.02 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.97 | 179,362 | 1.25 mm | 0 |
27 Dec 23 | Jessica D. Jensen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.78 | 136,055 | 922.45 k | 0 |
27 Dec 23 | Jessica D. Jensen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.91 | 13,766 | 108.89 k | 0 |